This video highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation.
In this video, Robert J. Soiffer, MD, of the Dana-Farber Cancer Institute in Boston, highlights research into the use of post-transplant therapies to prevent or treat disease recurrence following allogeneic stem cell transplantation (ASCT).
Soiffer gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
A panel of clinical pharmacists discussed strategies for mitigating toxicities across different multiple myeloma, lymphoma, and leukemia populations.